PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27089846-4	2016	The results demonstrated that both tolcapone and entacapone exhibited inhibitory effects on UGT1A1, UGT1A7, UGT1A9 and UGT1A10.	entacapone	49-59	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	92-98	
27089846-6	2016	It is noteworthy that the inhibition constants (Ki) of tolcapone and entacapone against bilirubin-O-glucuronidation in human liver microsomes (HLM) are determined as 0.68muM and 30.82muM, respectively, which means that the inhibition potency of tolcapone on UGT1A1 mediated bilirubin-O-glucuronidation in HLM is much higher than that of entacapone.	entacapone	69-79	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	258-264	
27089846-7	2016	Furthermore, the potential risks of tolcapone or entacapone via inhibition of human UGT1A1 were quantitatively predicted by the ratio of the areas under the plasma drug concentration-time curve (AUC).	entacapone	49-59	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	84-90	
11038168-6	2000	However, UGT1A1 was the only UGT capable of catalyzing the formation of two glucuronides of the catecholic entacapone.	entacapone	107-117	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	9-15